长春高新(000661.SZ)：GenSci142胶囊境内生产药品注册临床试验申请获批准

Core Viewpoint - Changchun High-tech (000661.SZ) announced that its subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd. (referred to as "Jinsai Pharmaceutical"), has received the Clinical Trial Approval Notification issued by the National Medical Products Administration, allowing the registration clinical trial application for GenSci142 capsules to proceed [1] Group 1 - Jinsai Pharmaceutical's GenSci142 capsules are classified as a Class 1 innovative biological product [1] - The intended use of GenSci142 capsules is for the treatment of bacterial vaginosis [1]